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]i; fura-2) or changes in endothelial membrane potential [4-{2-[6-(dioctylamino)-2-naphthalenyl]ethenyl}1-(3-sulfopropyl)-pyridinium (di-8-ANEPPS)]. Nitric oxide synthase and cyclooxygenase inhibitors were present throughout. Luminal application of UTP produced EDHFmediated dilations that correlated with significant endothelial hyperpolarization. The dilation and endothelial hyperpolarization were virtually abolished by inhibitors of IKCa channels but not by selective inhibitors of small or large conductance KCa channels (apamin and iberiotoxin, respectively). Additionally, direct stimulation of endothelial IKCa channels with 1-ethyl-2-benzimidazolinone (1-EBIO) produced endothelial hyperpolarization and vasodilatation that were blocked by inhibitors of IKCa channels. 1-EBIO hyperpolarized the endothelium but did not affect endothelial [Ca 2ϩ ]i. We conclude that the mechanism of EDHF-mediated dilations in cerebral arteries requires stimulation of endothelial IKCa channels to promote endothelial hyperpolarization and subsequent vasodilatation. calcium; brain; purinergic; small conductance potassium channels; large conductance potassium channels; endothelium-derived hyperpolarizing factor IN ADDITION TO NITRIC OXIDE (NO) and prostacyclin (PGI 2 ), a third endothelium-dependent vasodilatory process has been demonstrated in both cerebral and peripheral circulations. This latter vasodilatory process is distinct from NO-and PGI 2 -mediated mechanisms and is further characterized by its dependence on 1) an intact endothelium, 2) extracellular Ca 2ϩ , and 3) activation of calcium-sensitive potassium channels (K Ca ) to produce a smooth muscle hyperpolarization and subsequent vasodilatation (44) . This process was initially thought to involve production of an endothelial factor, which was termed endothelium-derived hyperpolarizing factor (EDHF) (7, 47) . Despite the given name, however, subsequent studies have not generally supported the role of a traditional factor in the response. Rather, EDHF-mediated vasodilatation appears to result from a far more complicated process requiring specific interactions between smooth muscle and endothelium. The precise mechanism by which EDHF-mediated vasodilatation occurs remains largely unresolved, in part, because the mechanism differs somewhat depending on the vessel bed studied (16, 20) .
There are, however, a number of unifying hallmarks common among EDHF-mediated dilations. One in particular is the essential involvement of K Ca [for review see Feletou and Vanhoutte (25) ]. Although it was initially assumed that the K Ca channels critical to EDHFmediated dilations were large conductance K Ca channels (BK Ca ) located on the smooth muscle (44) , it is now generally believed that the K Ca channels involved include intermediate conductance K Ca (IK Ca ) alone or in combination with small conductance K Ca (SK Ca ) located on the endothelium (3, 19, 20, 23, 30) . The mechanism by which endothelial K Ca channel activation translates into a smooth muscle hyperpolarization is still a matter of debate, but has been proposed to result from either 1) direct transfer of hyperpolarization from the endothelium via myoendothelial gap junctions (5, 6, 18, 20, 24, 45, 49) or 2) stimulation of smooth muscle inwardly rectifying K channels (K IR ) channels or Na (20) . One additional role for endothelial K Ca channels that is often assumed in intact arteries is to facilitate greater influx of extracellular Ca 2ϩ into the endothelium. It is proposed that activated endothelial K Ca channels hyperpolarize the endothelium, thus creating a greater electrical driving force for Ca 2ϩ influx [for review, see Nilius and Droogmans (42) ]. Given the essential roles for both Ca 2ϩ and K Ca channels in EDHF-mediated dilations, it is reasonable to speculate that endothelial K Ca channels contribute to endothelial Ca 2ϩ reaching or staying at the Ca 2ϩ threshold required for EDHF-mediated dilations. However, it must be noted that, whereas a role for endothelial K channel activation on Ca 2ϩ flux is widely supported from endothelial cell culture models (32, (35) (36) (37) 46) , there are little data available regarding endothelial intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) within the context of intact arteries. Furthermore, the data that exist from pressurized artery preparations appear to conflict regarding the relevance of membrane potential on endothelial Ca 2ϩ handling (27, 33, 50) . In the present studies, experiments were designed to determine the role and subtype of endothelial K Ca channels involved in EDHF-mediated dilations within pressurized cerebral arteries. Our use of an intact pressurized artery preparation is significant given that pressurized and nonpressurized vessel preparations differ in many respects, such as in resting membrane potential and [Ca 2ϩ ] i (29, 34) . We evaluated the following three hypotheses regarding the mechanism of EDHF-mediated dilations in pressurized middle cerebral arteries (MCAs): 1) IK Ca channel activation and endothelial hyperpolarization is critical to the EDHFdependent mechanism, 2) IK Ca channel activation and endothelial hyperpolarization is sufficient for EDHFmediated vasodilatation, and 3) IK Ca channel-mediated hyperpolarization of the endothelium is required for endothelial [Ca 2ϩ ] i to reach the threshold for initiating EDHF-mediated dilations.
MATERIALS AND METHODS
All experiments were approved by the Animal Protocol Review committee at Baylor College of Medicine. A total of 52 male Long-Evans rats (275-350 g) were anesthetized with isofluorane and decapitated. The brain was quickly harvested and placed in an ice-cold Krebs solution for the removal of the left and right MCAs. MCAs were kept in ice-cold Krebs until needed; all vessels were used within 4 h of being removed from the brain. Because the primary focus of these studies was to evaluate EDHF-mediated responses, inhibitors of NO synthase and cyclooxygenase [50 M N G -nitro-Larginine methyl ester (L-NAME) and 10 M indomethacin, respectively] were added to the luminal and abluminal Krebs buffer for all experiments.
Mounting of pressurized/perfused MCAs. MCAs were cannulated with two glass micropipettes as described in detail previously (39) . In brief, MCAs were secured to the micropipettes with 12-0 nylon suture and verified to be free of leaks. Warmed (37°C) and gassed (20% O 2-5% CO2-balance N2) Krebs was circulated through the chamber (abluminally) and perfused through the lumen of the artery (100 l/min). Mean intraluminal pressure was set to 85 mmHg and monitored by two inline pressure transducers. After mounting of the MCA, the vessel chamber was placed on the stage of an inverted fluorescence microscope equipped for the simultaneous measurement of artery diameter and either endothelial [Ca 2ϩ ]i or changes in endothelial membrane potential (⌬Vm).
Simultaneous measurement of endothelial [Ca 2ϩ ]i and diameter in intact cerebral arteries. The method for selectively measuring endothelial [Ca 2ϩ ]i and diameter in pressurized MCA has recently been described in detail (39) . Briefly, the endothelium was selectively loaded with fura-2 AM by adding it to the luminal perfusate. Fura-2 AM (0.67 M) was coadministered with pluronic F-127 (0.02%) to ensure a more even dispersion of fura-2 AM. The artery was perfused luminally with the fura-2 solution for 4 min before a washout period of 15 min. This short incubation with a low concentration of fura-2 AM ensured that the endogenous endothelial esterases were not overwhelmed, thus ensuring that the fura-2 free acid was contained to the endothelium.
Measurement of endothelial [Ca 2ϩ ]i was performed by alternating between 340 and 380 nm bandpass excitation filters and measuring the fura-2 fluorescence at 510 nm (28, 39 (34) .
Measurement of endothelial membrane potential in intact cerebral arteries. Endothelial membrane potential (V m) changes were measured in pressurized MCA by using a voltage-sensitive dye, 4-{2- [6- 
. This dye has previously been utilized to indicate changes in endothelial membrane potential in intact peripheral microvessels (1, 2, 10, 41) . Selective endothelial loading of di-8-ANEPPS was achieved by delivering di-8-ANEPPS (10 M/0.1% pluronic) luminally for 10 min followed by a 10-min washout period. During incubation, the dye becomes associated with the endothelial membrane. Confocal microscopy was utilized to ensure that the dye was confined to the endothelium (see Confocal microscopy of pressurized/perfused cerebral arteries). The ratio of the 560 and 620 emissions (excitation at 475 nm) changes with endothelial membrane potential such that a decrease in the ratio (560/620) indicates a hyperpolarization and an increase indicates a depolarization. The 560/620 ratios were acquired at a frequency of 12.5 Hz by using a fluorometer equipped with matched spinning excitation and emission filter wheels (C & L Instruments; Hummelstown, PA). Because changes in endothelial V m result in relatively small changes in fluorescence intensity, we felt it was important to eliminate changes in fluorescence intensity due to vasodilatation. We therefore used an inhibitor of smooth muscle actin polymerization (10 M cytochalasin D administered abluminally) (13) to dilate the arteries before administering the experimental drug. In some vessels, we used papaverine (300 M, abluminally) as a vasodilator and obtained similar results as with cytochalasin D (not shown). Artery diameter was measured simultaneously with di-8-ANEPPS fluorescence by using an infrared light source and infrared-sensitive video camera. However, because the arteries were predilated, the reported diameter responses to the experimental drugs were obtained in a separate set of vessels.
Confocal microscopy of pressurized/perfused cerebral arteries. Nipkow-type confocal microscopy was used to confirm that the di-8-ANEPPS dye was confined to the endothelium. The vessel chamber containing pressurized/perfused arteries was mounted on the stage of a Nikon TE-2000 fluorescence microscope (Nikon Instruments) coupled with a CARV confocal module set up for detection of di-8-ANEPPS fluorescence (Atto Instruments, Rockville, MD). The di-8-ANEPPS dye was loaded as described above before imaging.
Delivery of pharmacological compounds to the artery. Luminal delivery of pharmacological compounds was achieved by adding the compound to one of the luminal reservoirs connected to the inflow pipette. A miniaturized manifold system was utilized to substantially reduce the dead volume in the connecting tubing and thus speed delivery of the compound to the luminal compartment of the perfused artery. Abluminal delivery of pharmacological compounds was achieved by adding the compound to the abluminal perfusate reservoir. Compounds reached the luminal or extraluminal surface of the artery with a Ͻ30-s lag time.
Chemicals and buffers. All drugs and chemicals were obtained from Sigma (St. Louis, MO) with the exceptions of fura-2 AM (TefLabs; Austin, TX), di-8-ANEPPS (Molecular Probes; Eugene, OR), 1-ethyl-2-benzimidazolinone (1-EBIO; Tocris; Ellisville, MO), and 1- (calibration of di-8-ANEPPS) with the appropriate reduction in Na ϩ concentration to maintain an isotonic buffer; the remaining ingredients remained the same as the standard buffer. The Krebs buffer was gassed with a mixture of 20% O2-5% CO2-75% N2 to achieve a pH of 7.4 and a PCO2 of ϳ35 mmHg.
Iberiotoxin (IbTx; 100 nM) selectively blocks BKCa channels, whereas charybdotoxin (ChTx; 70 nM) is a nonselective BKCa/IKCa channel blocker. ChTx has also been shown to block the delayed rectifier (Kv) channels Kv1.2 and Kv1.3 (4). TRAM-34 (10 M) and clotrimazole (CTZ; 10 M) are IKCa channel blockers (54) . TRAM-34 is a recently developed structural analog of CTZ that is a potent IKCa channel blocker and lacks the cP450 inhibitory activity of CTZ (54). Apamin (Apa; 100 nM) is a selective SKCa channel blocker. High K ϩ (60 mM) Krebs buffer was used to nonselectively block all K channels.
Calculations and statistical methods. All data are presented as means Ϯ SE. Percent tone is defined as %tone ϭ [(Dmax Ϫ Dt)/ Dmax] ϫ 100, where Dt is the vessel diameter after development of spontaneous tone and D max is the maximum diameter of the artery corresponding to the Ca 2ϩ -free diameter. Percent diameter change is defined as %diameter For comparison of concentration-response curves, a twoway repeated-measures ANOVA was utilized followed by a Tukey's test for individual comparisons when appropriate. For comparison of multiple treatments within one group, a one-way repeated-measures ANOVA was used. Comparison of single treatments between two groups was performed by either paired or unpaired t-test. Significance was defined as P Ͻ 0.05.
RESULTS
Pressurized/perfused arteries developed spontaneous tone (constriction) within 20 to 40 min of mounting in the vessel chamber. The final tone developed by the artery was dependent on which combination of K ϩ channel inhibitors was used in addition to L-NAME and indomethacin and are summarized in Table 1 .
The ability to selectively deliver di-8-ANEPPS to the endothelium was evaluated for this isolated vessel preparation by confocal microscopy. In three separate vessels studied, di-8-ANEPPS fluorescence appeared uniformly along the lumen of the vessel and was clearly confined to the endothelium (data not shown). In a fourth vessel, the dye leaked from an open side branch and resulted in dye loading of the smooth muscle. The smooth muscle loading was evident as bright circumferential bands perpendicular to the direction of flow and was clearly evident by confocal or standard fluorescence microscopy.
The di-8-ANEPPS ratio changes were calibrated by using valinomycin ( ] o should produce endothelial V m values of Ϫ82 and Ϫ10 mV, respectively. The full range of the V m change would be 72 mV. The measured corresponding range of the di-8-ANEPPS ratio change to 5.9 and 90 mM [K ϩ ] o was 5.6 Ϯ 0.5% (n ϭ 3). Therefore, the calculated relationship between millivolt and ratio change is 12.9 mV for each 1% change in the 560/620 ratio. This relationship compares well with what others have reported from peripheral vessels (10-12 mV/1% ratio change) (2, 11) . Figure 1 shows a representative experiment in which endothelial ⌬V m was determined with di-8-ANEPPS. Cytochalasin D (10 M) administered abluminally produced a rapid and near-maximal dilation that was sustained throughout the experiment (Fig. 1A) . Fluorescence intensities (F 560 and F 620 ) both decreased on artery dilation (Fig. 1B) . The drop in fluorescence resulted from the near and far portions of the vessel (from the objective) going beyond the depth of field of the objective. However, as the drops in intensities were 
Values are means Ϯ SE; n ϭ number of arteries. N G -nitro-Larginine methyl ester (L-NAME) and indomethacin were present throughout. Baseline reflects the diameter following the addition of a given K ϩ channel blocker. Max, diameter equivalent to that in Ca 2ϩ -free Krebs solution; L, luminal delivery only; LA, luminal and abluminal delivery of the blockers; high K ϩ , 60 mM K ϩ Krebs solution; ChTx, charybdotoxin (70 nM); IbTx, iberiotoxin (100 nM); ChTx/Apa, charybdotoxin (70 nM) plus apamin (100 nM). * P Ͻ 0.05
equivalent for each wavelength, the 560/620 ratio remained essentially the same (Fig. 1C) . The luminal addition of UTP (10 Ϫ5 M) produced minimal further change in diameter, whereas the F 560 (dotted line) and F 620 (solid line) changed in opposite directions (F 560 decreased and F 620 increased; Fig. 1B) . The 560/620 ratio decreased by ϳ4%, thus indicating an endothelial hyperpolarization.
Diameter and endothelial V m responses to luminally delivered UTP (10 Ϫ5 M) were evaluated in the absence and presence of ChTx (70 nM). Diameter responses are reported from a separate group of vessels, because cytochalasin D was used to predilate the endothelial V m group vessels. Diameter responses to UTP are reported as the %maximum achievable area under the curve over a 200-s time period (see MATERIALS AND METH-ODS). The diameter and V m results are summarized in Fig. 2 . Luminal UTP produced significant vasodilatation (88 Ϯ 3%) and endothelial hyperpolarization (Ϫ42 Ϯ 2 mV). The addition of ChTx to the bath virtually eliminated both the dilation (27 Ϯ 14%) and endothelial hyperpolarization to UTP (Ϫ5 Ϯ 13 mV). These results indicate that the dilation and endothelial hyperpolarization are mediated primarily by ChTxsensitive K channels.
Because ChTx has been shown to inhibit both BK Ca and IK Ca channels as well as some voltage-sensitive K channels (K v1.2 and K v1.3 ) (4), we sought to determine which ChTx-sensitive channels were essential to the EDHF-mediated response. The %max diameter (Fig. 3) reflects the measured AUC in response to UTP as a percentage of theoretical maximum AUC over a 200-s period (see MATERIALS AND METHODS). Control responses to luminal 10 M UTP produced significant artery vasodilatation (82 Ϯ 2%) over the measurement period. Application of a selective BK Ca channel blocker (IbTx 100 nM) had no significant effect on EDHF-mediated dilations to UTP (73 Ϯ 11%). Similarly, application of a selective SK Ca channel blocker (100 nM Apa) had no effect on dilations to UTP (88 Ϯ 4%). However, application of a selective IK Ca channel blocker (TRAM-34 10 M) significantly reduced EDHF-mediated dilations to Responses to luminal UTP were evaluated in the absence and presence of charybdotoxin (ChTx; 70 nM). The diameter and ⌬Vm responses were performed separately, because cytochalasin D was used to predilate the vessels in which ⌬Vm was measured (n ϭ 4-9). All experiments were performed in the presence of L-NAME and indomethacin. *P Ͻ 0.05 compared with control group by unpaired t-test. , and the ratio of F560/F620 (C). The ratio of F560/F620 reflects membrane potential changes in the endothelium in which hyperpolarization is reflected by a decrease in the ratio, and depolarization is reflected by an increase in the ratio. Cytochalasin D, an inhibitor of smooth muscle actin polymerization, was used to predilate the artery to eliminate any motion artifact associated with the response to UTP. Arrows indicate the addition of abluminal cytochalasin D (10 M) followed by luminal UTP (10 M). Note that UTP resulted in a decrease in the ratio due to opposite changes in F560 and F620. All experiments were performed in the presence of N G -nitro-L-arginine methyl ester (L-NAME) and indomethacin.
UTP (32 Ϯ 4%). Combined inhibition of IK Ca and K v channels (TRAM-34 and 3 mM 4-aminopyridine) similarly reduced dilations to UTP (25 Ϯ 6%), although the inhibition was not significantly different than with TRAM-34 alone (P ϭ 0.84, two-way repeated-measures ANOVA). Thus it appears that IK Ca channels by themselves contribute considerably to the EDHF-mediated dilation and likely reflect the critical K channel blocked by ChTx.
If activation of IK Ca channels is the critical downstream event from elevated endothelial [Ca 2ϩ ] i in the mechanism of EDHF-mediated vasodilatation, then direct activation of IK Ca channels should produce a dilatation. We therefore utilized an IK Ca channel opener (1-EBIO) to determine the effect of direct activation of endothelial IK Ca channels on vessel diameter. Luminal administration of 1-EBIO (1 to 300 M) produced concentration-dependent vasodilatation that was significantly inhibited by nonselective K channel inhibition with luminal 60 mM K ϩ (Fig. 4) . Furthermore, when 1-EBIO was administered abluminally (smooth muscle side), responses were significantly attenuated compared with luminal administration.
Although 1-EBIO has been demonstrated to be an effective activator of IK Ca channels (15, 21, 31, 51) , it was still incumbent on us to confirm that 1-EBIO acts specifically via stimulation of IK Ca channels and produces the predicted hyperpolarization of the endothelium in this vessel preparation. Figure 5 summarizes diameter responses as a percentage of control dilations in response to luminal delivery of 1-EBIO (300 M) with selected BK Ca and IK Ca channel blockers. Note that 1-EBIO produced a significant dilation that was unaffected by a selective BK Ca channel blocker (IbTx 100 nM, n ϭ 3) but was significantly attenuated by a BK Ca /IK Ca channel blocker (ChTx 70 nM, n ϭ 3) or by an IK Ca channel blocker (CTZ 10 M, n ϭ 4). In addition, Fig. 6 shows that luminal 1-EBIO resulted in significant hyperpolarization of the endothelium (Ϫ26 Ϯ 4 mV) that was significantly attenuated in the presence of 100 nM ChTx (Ϫ9 Ϯ 2 mV, P Ͻ 0.01). Taken as a whole, these data indicate that luminal 1-EBIO acts primarily by stimulating endothelial IK Ca channels. Furthermore, the direct activation of endothelial IK Ca channels is sufficient to produce significant endothelial hyperpolarization and subsequent vasodilatation.
We then sought to determine whether 1-EBIO-mediated vasodilatation was a direct result of IK Ca channelmediated endothelial hyperpolarization or whether perhaps IK Ca -mediated endothelial hyperpolarization was simply a means to increase endothelial [Ca 2ϩ ] i . For instance, as the endothelial membrane potential The filled bar represents the pooled control response to UTP performed before the addition of IbTx (100 nM; n ϭ 3), Apa (100 nM; n ϭ 5), TRAM-34 (10 M; n ϭ 8), or TRAM-34 plus 4-AP (3 mM; n ϭ 5). A washout period of at least 30 min was allowed between the two UTP responses. L-NAME and indomethacin were present throughout. *P Ͻ 0.05 compared with control group by paired t-test. Fig. 4 . Summary of %diameter change in response to 1-ethyl-2-benzimidazolinone (1-EBIO). 1-EBIO was delivered luminally (n ϭ 7) as well as abluminally (n ϭ 6). In addition, 1-EBIO was delivered luminally in the presence of 60 mM K ϩ containing Krebs (luminal w/high K ϩ ; n ϭ 5). L-NAME and indomethacin were present throughout. Abluminal and luminal with high K ϩ responses were significantly different from the luminal response (2-way repeated measures ANOVA). * Individual differences compared with luminal response (P Ͻ 0.05, Tukey's test). has been shown to modulate Ca 2ϩ influx, a possible indirect mechanism for 1-EBIO-dependent dilations could be to promote endothelial Ca 2ϩ influx secondary to endothelial hyperpolarization. In this latter scenario, 1-EBIO-mediated hyperpolarization would promote an influx of Ca 2ϩ , thus activating some other pathway or enzyme in the EDHF-dependent mechanism. To evaluate these possible mechanisms of 1-EBIO-mediated vasodilatation, endothelial [Ca 2ϩ ] i was measured in response to 1-EBIO. Endothelial [Ca 2ϩ ] i was determined fluorometrically by selectively loading the endothelium with fura-2 as demonstrated previously (39, 40) . The effect of luminal 1-EBIO on endothelial [Ca 2ϩ ] i and diameter were determined simultaneously. Luminal UTP (10 Ϫ5 M) was subsequently administered to the same vessel as a positive control. Figure 7A summarizes artery diameter in response to 300 M 1-EBIO. The dilation to UTP (10 Ϫ5 M) reflects a steady-state diameter equivalent to 99 Ϯ 4% of maximum. Figure 7B summarizes the corresponding endothelial [Ca 2ϩ ] i in response to 1-EBIO and to the subsequent addition of UTP. Note that 1-EBIO did not alter endothelial [Ca 2ϩ ] i despite significant artery dilation. Importantly, the lack of increase in endothelial [Ca 2ϩ ] i to 1-EBIO was not due to an inability of the endothelium to increase [Ca 2ϩ ] i , as significant increases to luminal UTP were obtained from the same arteries. Thus it appears that 1-EBIOmediated vasodilatation via stimulation of endothelial IK Ca channels and endothelial hyperpolarization does not result from an increase in endothelial [Ca 2ϩ ] i . Rather, it appears that vasodilatation results directly from IK Ca channel activation and subsequent endothelial hyperpolarization.
As EDHF-mediated dilations have been shown to critically depend on elevations in endothelial [Ca 2ϩ ] i , we also sought to determine whether the endothelial hyperpolarization was required for the production of sufficient increases in endothelial [Ca 2ϩ ] i to elicit EDHF-mediated dilations with an EDHF-dependent agonist. Artery diameter and endothelial [Ca 2ϩ ] i were measured simultaneously after the addition of luminal UTP (10 Ϫ7 to 10 Ϫ5 M). Figure 8 shows responses for control, high luminal K ϩ , and ChTx/Apa. The addition of either luminal K ϩ (nonselective neutralization of all endothelial K ϩ channels) or ChTx/Apa (inhibition of all K Ca ) resulted in complete elimination of EDHF-mediated dilations (Fig. 8A) . However, peak endothelial Ca 2ϩ responses were not at all attenuated by the inhibition of either K Ca channels or all K ϩ channels (Fig.  8B) . Furthermore, plateau [Ca 2ϩ ] i (measured at 200 s from onset of Ca 2ϩ increase) was not attenuated after K ϩ channel inhibition in either group (see Table 2 ). ]i (B) in response to 300 M 1-EBIO followed by 10 M UTP (n ϭ 4). 1-EBIO and UTP were each delivered luminally. Responses to UTP were performed as a control to verify that there was not generalized dysfunction in endothelial Ca 2ϩ regulation. L-NAME and indomethacin were present throughout. *P Ͻ 0.05 compared with baseline values by 2-way repeated-measures ANOVA followed by Tukey's test for individual comparisons. Fig. 6 . Summary of endothelial ⌬Vm in response to luminal 1-EBIO. 1-EBIO (300 M) was administered in the absence and presence of ChTx (70 nM; n ϭ 5 each). L-NAME and indomethacin were present throughout. *P Ͻ 0.01 compared with ChTx(-) response by unpaired t-test.
DISCUSSION
The present studies provide new evidence for a critical role of endothelial IK Ca channels in EDHF-mediated dilations in pressurized cerebral arteries. Herein, we evaluated the hypotheses that 1) IK Ca channel activation and endothelial hyperpolarization is critical for agonist-mediated EDHF responses, and 2) selective activation of IK Ca channels is sufficient to promote endothelial hyperpolarization and vasodilatation. These hypotheses were addressed in two ways. First, we used UTP to evaluate the role of IK Ca channel activation on endothelial hyperpolarization and vasodilatation in response to an EDHF-dependent agonist. Second, we used an IK Ca channel agonist (1-EBIO) to evaluate the effect of directly activating endothelial IK Ca channels on endothelial membrane potential and vessel diameter. We also evaluated the hypothesis that IK Ca channel-mediated hyperpolarization of the endothelium is required for endothelial [Ca 2ϩ ] i to reach the threshold for initiating EDHF-mediated dilations within the context of pressurized cerebral arteries. The hypotheses are addressed further below.
The first step in demonstrating that endothelial IK Ca channel activation results in endothelial hyperpolarization and vasodilatation was to develop a method for measuring endothelial membrane potential in pressurized arteries. The gold standard for measuring cell membrane potential has traditionally been by microelectrode impalement. However, measurement of endothelial membrane potential in the pressurized MCA preparation is exceedingly difficult, as it would entail passing a microelectrode through two to three layers of smooth muscle and into a very thin endothelial cell. To our knowledge, measurement of endothelial membrane potential by microelectrode in a pressurized artery has only been reported by a single laboratory (24, 53) . We therefore sought to apply a recently developed technique that utilizes a ratiometric voltage-sensitive fluorescent dye, di-8-ANEPPS, to measure changes in membrane potential. Di-8-ANEPPS has been used successfully for that purpose in a variety of tissues, including the endothelium from intact pressurized peripheral blood vessels (1, 2, 10, 11, 41) . In the present study, we demonstrated that luminally applied di-8-ANEPPS could be confined to the endothelium and used to indicate changes in endothelial V m in a pressurized cerebral artery preparation. We also performed an in vitro calibration of the dye and determined a relationship of 12.9 mV/1% ratio change. This relationship compares well with what others have reported from peripheral vessels (10-12 mV/1% ratio change) and thus appears to be a reasonable approximation of actual membrane potential change (2, 11) .
Luminal application of UTP produced significant hyperpolarization of the endothelium (⌬ ϭ Ϫ43 mV) as well as maximal EDHF-dependent dilations. Furthermore, the endothelial hyperpolarization to UTP was virtually abolished after the administration of ChTx. These data demonstrated that EDHF-mediated dilations to UTP involve significant endothelial hyperpolarization and that ChTx-sensitive channels were the primary effectors of that hyperpolarization (Fig. 2) . The extent to which UTP hyperpolarized the endothelium falls within the upper range of agonist-mediated endothelial hyperpolarization (⌬ ϭ Ϫ20 to Ϫ45 mV) reported from nonpressurized peripheral tissues (3, 8, 12, 20, 21, 30, 32, 38) . To our knowledge, only one . All experiments were performed in the presence of L-NAME and indomethacin. Responses to UTP were performed in the presence of L-NAME/indomethacin alone (control; n ϭ 5), with luminal 60 mM K ϩ (high K ϩ ; n ϭ 5), and in the presence of ChTx/Apa (n ϭ 4). Diameter responses for both high Kϩ and ChTx/Apa were significantly different compared with control (2-way repeated-measures ANOVA). * Individual differences (P Ͻ 0.05, Tukey's test).
previous study (53) has reported endothelial membrane potential in an EDHF-mediated response from a pressurized vessel. In that study, Welsh and Segal (53) demonstrated endothelial hyperpolarizations to ACh (⌬15-32 mV) within hamster cheek pouch arterioles. Interestingly, the resting endothelial membrane potential that they report (Ϫ30 mV) is notably depolarized from that of nonpressurized artery endothelium (Ϫ42 to Ϫ65 mV) (14, 21, 22, 26, 38) . Thus a more depolarized resting endothelial membrane potential in the pressurized artery would permit a greater possible hyperpolarization and might contribute to the reason that our hyperpolarization values fall at the upper end of the nonpressurized range.
Luminal 1-EBIO was used to determine the effect of activating endothelial IK Ca channels directly. Activation of endothelial IK Ca channels with 1-EBIO resulted in vasodilatation and endothelial hyperpolarization (⌬ ϭ Ϫ26 mV). Furthermore, both vasodilatation and hyperpolarization were significantly attenuated after the application of ChTx. It should be noted that, whereas 1-EBIO has been shown to be a good activator of IK Ca channels and to possess good selectivity of IK Ca channels over BK Ca channels (15, 21, 31, 51) , it may have additional effects that should be keep in mind. For instance, 1-EBIO has been shown to activate certain SK Ca channels (43) as well as to promote relaxation of the smooth muscle through a mechanism not involving hyperpolarization (51) . In our studies, 1-EBIO produced concentration-dependent dilations when delivered luminally (to the endothelium). When delivered abluminally (to the smooth muscle), however, the dilations were significantly attenuated. The significantly greater potency of 1-EBIO when delivered luminally versus abluminally suggests that the primary site of action is on the endothelium. The vasodilatation to luminal 1-EBIO was unaffected by the presence of a selective BK Ca channel blocker, IbTx, demonstrating that BK Ca channels are not involved in the 1-EBIO response (Fig. 5) . However, vasodilatation was significantly attenuated when 1-EBIO was administered in the presence of either ChTx, CTZ, or high luminal K ϩ (Figs. 4 and 5 ). Our data indicate that SK Ca channels do not play a significant role in the vasodilatation to 1-EBIO in this particular preparation, because the inhibition with ChTx or CTZ was not significantly different from that with nonspecific K channel inhibition (high luminal K ϩ ). Together, these data indicate that luminal 1-EBIO acts primarily on endothelial IK Ca channels in the pressurized MCA preparation. Furthermore, endothelial IK Ca channels are capable of promoting significant endothelial hyperpolarization when directly activated.
Although arteries dilated subsequently to 1-EBIOmediated endothelial hyperpolarization, it was not clear where endothelial hyperpolarization fit into the mechanism. Because endothelial membrane potential has been shown to modulate Ca 2ϩ influx, a possible indirect mechanism for 1-EBIO-dependent dilations could be to promote endothelial Ca 2ϩ influx secondary to endothelial hyperpolarization. Therefore, whereas 1-EBIO produced significant endothelium-dependent dilations by activating endothelial IK Ca channels, it was still necessary to determine whether the dilation resulted directly from IK Ca channel activation and endothelial hyperpolarization or whether the resulting endothelial hyperpolarization triggered another Ca 2ϩ -dependent mechanism by promoting endothelial Ca 2ϩ influx. For instance, if 1-EBIO resulted in an increase in endothelial [Ca 2ϩ ] i , then the vasodilatation to 1-EBIO (or IK Ca channel activation) could ultimately result from subsequent production of a Ca 2ϩ -dependent relaxing factor(s). However, the addition of 1-EBIO did not alter endothelial [Ca 2ϩ ] i from resting values despite the significant vasodilatory effect of 1-EBIO (Fig. 7) . Taken as a whole, these data indicate that 1-EBIO-dependent vasodilatation of cerebral arteries is mediated primarily by direct activation of endothelial IK Ca ] i required to produce significant activation of IK Ca channels (250-500 nM Ca 2ϩ ) (42) . Whereas the primary role for IK Ca channel activation in the EDHF mechanism thus appears to be downstream of calcium, a secondary role might be to augment agonist-mediated endothelial [Ca 2ϩ ] i responses. In cultured endothelial cells, Ca 2ϩ influx has been shown to be dependent on membrane potential with hyperpolarization driving greater Ca 2ϩ influx (32, 35, 46) . Given the IK Ca channel activation and endothelial hyperpolarization that results from EDHF-dependent agonists (Fig. 2) , one would therefore presume that IK Ca channel activation would augment agonist-mediated endothelial [Ca 2ϩ ] i responses. Conversely, one would expect that interrupting that positive feedback system by inhibiting IK Ca channels would result in reduced [Ca 2ϩ ] i responses to EDHF-dependent agonists. Thus IK Ca channel blockers might also be able to inhibit or modulate EDHF-mediated dilations by pre-venting endothelial [Ca 2ϩ ] i from reaching the EDHFinitiating threshold. It must be noted, however, that such a scenario is reasonable only as long as one assumes that the relationship between membrane potential and Ca 2ϩ flux applies beyond cultured endothelial cells. Although that assumption is often made in the literature, there are very few studies that provide data regarding the role of membrane potential on endothelial Ca 2ϩ flux in intact arteries. The issue is further complicated given that endothelial Ca 2ϩ responses from intact arteries are more complex to interpret given the likely contribution of smooth muscle to endothelial [Ca 2ϩ ] i (17) . In intact peripheral arteries, agonist-mediated Ca 2ϩ flux has been shown to be reduced (27, 33) or unchanged (27, 50) in the presence of K channel blockers. Interestingly, the studies that reported reduced [Ca 2ϩ ] i responses used high [K ϩ ] o to nonselectively block K channels (and presumably depolarize the endothelium and smooth muscle) (27, 33) . In contrast, ChTx/Apa was without effect on endothelial [Ca 2ϩ ] i , despite effectively blocking the agonistmediated dilator response (27, 50 Table 2 ). It is not clear why these studies appear to conflict regarding the role of membrane potential in modulating endothelial [Ca 2ϩ ] i . One possible explanation is that the relative role of membrane potential is dependent on the contribution of other modulating factors such as intracellular Ca 2ϩ stores or Ca 2ϩ flux from coupled smooth muscle cells (17) . However, irrespective of the reason, our data demonstrate that endothelial hyperpolarization does not significantly affect endothelial [Ca 2ϩ ] i in response to UTP in intact cerebral arteries. Furthermore, these data reinforce the conclusion that the critical role of endothelial IK Ca channel activation is entirely downstream of endothelial [Ca 2ϩ ] i in the EDHF-dependent mechanism.
Taken as a whole, these data demonstrate that EDHF-mediated dilations in the cerebral circulation require activation of endothelial IK Ca channels. In addition, direct activation of endothelial IK Ca channels (1-EBIO) produces endothelial hyperpolarization and vasodilatation that mimic the EDHF-mediated response. Because the vasodilatory effect of direct IK Ca channel activation does not involve an increase in endothelial [Ca 2ϩ ] i , it appears that the critical role for endothelial IK Ca channels is downstream of endothelial [Ca 2ϩ ] i in the EDHF mechanism. Thus the present data support a model in which increased endothelial [Ca 2ϩ ] i acts as the physiological activator of endothelial IK Ca channels with IK Ca channel activation and endothelial hyperpolarization being critical events in promoting the subsequent smooth muscle hyperpolarization. Further studies are required to determine the specific mechanism by which endothelial IK Ca channel activation ultimately effects smooth muscle hyperpolarization and vasodilatation in cerebral arteries.
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